Targeting of the MUC1-C Oncoprotein in Colitis-Associated Colorectal Cancer

doi 10.21236/ada617417
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Targeting Cysteine-Mediated Dimerization of the MUC1-C Oncoprotein in Human Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2011English

Targeting MUC1-C Inhibits the AKT-S6K1-elF4A Pathway Regulating TIGAR Translation in Colorectal Cancer

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2017English

MUC1 Oncoprotein Blocks Nuclear Targeting of C-Abl in the Apoptotic Response to DNA Damage

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2006English

The MUC1-C Oncoprotein as a Target in Hematologic Malignancies

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2010English

Inhibition of the MUC1-C Oncoprotein Is Synergistic With Cytotoxic Agents in the Treatment of Breast Cancer Cells

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2013English

MUC1-C Oncoprotein Promotes STAT3 Activation in an Autoinductive Regulatory Loop

Science Signaling
BiochemistryCell BiologyMolecular Biology
2011English

The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer

Mediators of Inflammation
ImmunologyCell Biology
2017English

The Protective Role of Bacteroides Fragilis in a Murine Model of Colitis-Associated Colorectal Cancer

mSphere
MicrobiologyMolecular Biology
2018English

Colitis-Associated Colorectal Cancer Driven by T-Bet Deficiency in Dendritic Cells

Cancer Cell
Cancer ResearchOncologyCell Biology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy